_id

690da995ccc777a4e85d085d

Ticker

ADCT

Name

ADC Therapeutics SA

Exchange

NYSE

Address

BiopOle, Epalinges, Switzerland, 1066

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.adctherapeutics.com

Description

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

Last Close

4.18

Volume

388157

Current Price

4.23

Change

1.1961722488038447

Last Updated

2025-11-28T11:50:59.328Z

Image

data:image/webp;base64,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

Ipo Date

1979-03-16T00:00:00.000Z

Market Cap

536387872

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.19150000000000003

Sentiment Sources

4

Rating

4.6667

Target Price

8

Strong Buy

4

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

16427000

Cost Of Revenue

1202000

Gross Profit

15225000

Operating Expenses

46194000

Operating Income

-30969000

Interest Expense

13392000

Pretax Income

-40966000

Net Income

-40966000

Eps

-0.30023481578506056

Dividends Per Share

-

Shares Outstanding

123877111

Income Tax Expense

-

EBITDA

-27452000

Operating Margin

-188.52498934680708

Total Other Income Expense Net

-9997000

Cash

234738000

Short Term Investments

-

Receivables

22918000

Inventories

18042000

Total Current Assets

287149000

Property Plant Equipment

1393000

Total Assets

289758000

Payables

8119000

Short Term Debt

933000

Long Term Debt

115206000

Total Liabilities

527941000

Equity

-238183000

Depreciation

122000

Change In Working Capital

392000

Cash From Operations

-29630000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-198000

Net Change In Cash

-29822000

PE

-

PB

-2.423215925653804

ROE

17.199380308418316

ROA

-14.138004817813485

FCF

-29630000

Fcf Percent

-1.8037377488281487

Piotroski FScore

1

Health Score

29

Deep Value Investing Score

1.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2

Growth Investing Score

1.5

Momentum Investing Score

2.5

Net Net Investing Score

1

Quality Investing Score

1.5

Value Investing Score

2

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

16427000

Quarters > 0 > income Statement > cost Of Revenue

1202000

Quarters > 0 > income Statement > gross Profit

15225000

Quarters > 0 > income Statement > operating Expenses

46194000

Quarters > 0 > income Statement > operating Income

-30969000

Quarters > 0 > income Statement > interest Expense

13392000

Quarters > 0 > income Statement > pretax Income

-40966000

Quarters > 0 > income Statement > net Income

-40966000

Quarters > 0 > income Statement > eps

-0.30023481578506056

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

136446534

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-27452000

Quarters > 0 > income Statement > operating Margin

-188.52498934680708

Quarters > 0 > income Statement > total Other Income Expense Net

-9997000

Quarters > 0 > balance Sheet > cash

234738000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

22918000

Quarters > 0 > balance Sheet > inventories

18042000

Quarters > 0 > balance Sheet > total Current Assets

287149000

Quarters > 0 > balance Sheet > property Plant Equipment

1393000

Quarters > 0 > balance Sheet > total Assets

289758000

Quarters > 0 > balance Sheet > payables

8119000

Quarters > 0 > balance Sheet > short Term Debt

933000

Quarters > 0 > balance Sheet > long Term Debt

115206000

Quarters > 0 > balance Sheet > total Liabilities

527941000

Quarters > 0 > balance Sheet > equity

-238183000

Quarters > 0 > cash Flow > net Income

-40966000

Quarters > 0 > cash Flow > depreciation

122000

Quarters > 0 > cash Flow > change In Working Capital

392000

Quarters > 0 > cash Flow > cash From Operations

-29630000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-198000

Quarters > 0 > cash Flow > net Change In Cash

-29822000

Quarters > 0 > ratios > PE

-0.30023481578506056

Quarters > 0 > ratios > PB

-2.423215925653804

Quarters > 0 > ratios > ROE

17.199380308418316

Quarters > 0 > ratios > ROA

-14.138004817813485

Quarters > 0 > ratios > FCF

-29630000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-1.8037377488281487

Quarters > 0 > health Score

29

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

18839000

Quarters > 1 > income Statement > cost Of Revenue

836000

Quarters > 1 > income Statement > gross Profit

18003000

Quarters > 1 > income Statement > operating Expenses

62150000

Quarters > 1 > income Statement > operating Income

-44147000

Quarters > 1 > income Statement > interest Expense

12997000

Quarters > 1 > income Statement > pretax Income

-55392000

Quarters > 1 > income Statement > net Income

-56646000

Quarters > 1 > income Statement > eps

-0.498015892936799

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

113743358

Quarters > 1 > income Statement > income Tax Expense

1254000

Quarters > 1 > income Statement > EBITDA

-41555000

Quarters > 1 > income Statement > operating Margin

-234.3383406762567

Quarters > 1 > income Statement > total Other Income Expense Net

-11245000

Quarters > 1 > balance Sheet > cash

264560000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

26184000

Quarters > 1 > balance Sheet > inventories

17763000

Quarters > 1 > balance Sheet > total Current Assets

318755000

Quarters > 1 > balance Sheet > property Plant Equipment

1489000

Quarters > 1 > balance Sheet > total Assets

321561000

Quarters > 1 > balance Sheet > payables

9616000

Quarters > 1 > balance Sheet > short Term Debt

1792000

Quarters > 1 > balance Sheet > long Term Debt

114473000

Quarters > 1 > balance Sheet > total Liabilities

520745000

Quarters > 1 > balance Sheet > equity

-199184000

Quarters > 1 > cash Flow > net Income

-56646000

Quarters > 1 > cash Flow > depreciation

1490000

Quarters > 1 > cash Flow > change In Working Capital

21566000

Quarters > 1 > cash Flow > cash From Operations

-24087000

Quarters > 1 > cash Flow > capital Expenditures

11580

Quarters > 1 > cash Flow > cash From Investing

-11575

Quarters > 1 > cash Flow > cash From Financing

93783000

Quarters > 1 > cash Flow > net Change In Cash

69859000

Quarters > 1 > ratios > PE

-0.498015892936799

Quarters > 1 > ratios > PB

-2.4155273733834046

Quarters > 1 > ratios > ROE

28.43903124748976

Quarters > 1 > ratios > ROA

-17.6159422318005

Quarters > 1 > ratios > FCF

-24098580

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-1.279185731726737

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

23033000

Quarters > 2 > income Statement > cost Of Revenue

2061000

Quarters > 2 > income Statement > gross Profit

20972000

Quarters > 2 > income Statement > operating Expenses

49436000

Quarters > 2 > income Statement > operating Income

-28464000

Quarters > 2 > income Statement > interest Expense

12230000

Quarters > 2 > income Statement > pretax Income

-38437000

Quarters > 2 > income Statement > net Income

-38602000

Quarters > 2 > income Statement > eps

-0.36008530930481075

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

107202374

Quarters > 2 > income Statement > income Tax Expense

165000

Quarters > 2 > income Statement > EBITDA

-25687000

Quarters > 2 > income Statement > operating Margin

-123.57921243433334

Quarters > 2 > income Statement > total Other Income Expense Net

-9973000

Quarters > 2 > balance Sheet > cash

194701000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

31762000

Quarters > 2 > balance Sheet > inventories

17447000

Quarters > 2 > balance Sheet > total Current Assets

257988999

Quarters > 2 > balance Sheet > property Plant Equipment

13387000

Quarters > 2 > balance Sheet > total Assets

272539000

Quarters > 2 > balance Sheet > payables

15592000

Quarters > 2 > balance Sheet > short Term Debt

1368000

Quarters > 2 > balance Sheet > long Term Debt

113823000

Quarters > 2 > balance Sheet > total Liabilities

510762000

Quarters > 2 > balance Sheet > equity

-238223000

Quarters > 2 > cash Flow > net Income

-38602000

Quarters > 2 > cash Flow > depreciation

801000

Quarters > 2 > cash Flow > change In Working Capital

-29515000

Quarters > 2 > cash Flow > cash From Operations

-56334000

Quarters > 2 > cash Flow > capital Expenditures

264000

Quarters > 2 > cash Flow > cash From Investing

-264000

Quarters > 2 > cash Flow > cash From Financing

271000

Quarters > 2 > cash Flow > net Change In Cash

-56166000

Quarters > 2 > ratios > PE

-0.36008530930481075

Quarters > 2 > ratios > PB

-1.9035359390990796

Quarters > 2 > ratios > ROE

16.20414485587034

Quarters > 2 > ratios > ROA

-14.16384444061217

Quarters > 2 > ratios > FCF

-56598000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-2.457256979116919

Quarters > 2 > health Score

27

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

16910000

Quarters > 3 > income Statement > cost Of Revenue

1371000

Quarters > 3 > income Statement > gross Profit

15539000

Quarters > 3 > income Statement > operating Expenses

47975000

Quarters > 3 > income Statement > operating Income

-32436000

Quarters > 3 > income Statement > interest Expense

11919000

Quarters > 3 > income Statement > pretax Income

-31048000

Quarters > 3 > income Statement > net Income

-30727000

Quarters > 3 > income Statement > eps

-0.2915367056591357

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

105396677

Quarters > 3 > income Statement > income Tax Expense

-321000

Quarters > 3 > income Statement > EBITDA

-18832000

Quarters > 3 > income Statement > operating Margin

-191.8154937906564

Quarters > 3 > income Statement > total Other Income Expense Net

1388000

Quarters > 3 > balance Sheet > cash

250867000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

20316000

Quarters > 3 > balance Sheet > inventories

18387000

Quarters > 3 > balance Sheet > total Current Assets

307390000

Quarters > 3 > balance Sheet > property Plant Equipment

13429000

Quarters > 3 > balance Sheet > total Assets

321980000

Quarters > 3 > balance Sheet > payables

18029000

Quarters > 3 > balance Sheet > short Term Debt

1371000

Quarters > 3 > balance Sheet > long Term Debt

113632000

Quarters > 3 > balance Sheet > total Liabilities

524622000

Quarters > 3 > balance Sheet > equity

-202642000

Quarters > 3 > cash Flow > net Income

-30727000

Quarters > 3 > cash Flow > depreciation

236000

Quarters > 3 > cash Flow > change In Working Capital

6348000

Quarters > 3 > cash Flow > cash From Operations

-21852000

Quarters > 3 > cash Flow > capital Expenditures

90000

Quarters > 3 > cash Flow > cash From Investing

-90000

Quarters > 3 > cash Flow > cash From Financing

-1120000

Quarters > 3 > cash Flow > net Change In Cash

-23405000

Quarters > 3 > ratios > PE

-0.2915367056591357

Quarters > 3 > ratios > PB

-2.2000767052733394

Quarters > 3 > ratios > ROE

15.163194204557792

Quarters > 3 > ratios > ROA

-9.54313932542394

Quarters > 3 > ratios > FCF

-21942000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-1.2975753991720875

Quarters > 3 > health Score

27

Valuation > metrics > PE

-0.30023481578506056

Valuation > metrics > PB

-2.423215925653804

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

17.199380308418316

Profitability > metrics > ROA

-14.266460966257934

Profitability > metrics > Net Margin

-2.493821148109819

Profitability > final Score

34

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-2.3125

Risk > final Score

21

Risk > verdict

High

Liquidity > metrics > Current Ratio

31.722160848431287

Liquidity > metrics > Quick Ratio

29.72901016349978

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

40

Prev Profitabilities > 1

32

Prev Profitabilities > 2

30

Prev Risks > 0

16

Prev Risks > 1

21

Prev Risks > 2

19

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:11:54.280Z